|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/26 | (2006.01) |
| A61K 38/26 | (2013.01) | ||
| A61P 1/00 | (2006.01) | ||
| A61P 1/00 | (2018.01) |
| (11) | Patento numeris | 3881861 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21150552.4 |
| Europos patento paraiškos padavimo data | 2018-06-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-09-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-07-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201709643 | 2017-06-16 | GB | |
| 201714203 | 2017-09-05 | GB | |
| 201800873 | 2018-01-19 | GB |
| (72) |
Sonne, Kim , DK
Mouritzen, Ulrik , DK
Glerup, Peter , DK
Jeppesen, Palle Bekker , DK
|
| (73) |
Zealand Pharma A/S ,
Sydmarken 11, 2860 Søborg,
DK
|
| (54) | DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |
| DOSAGE REGIMES FOR THE ADMINISTRATION OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES |